Front Oncol. 2021 Nov 10;11:771802. doi: 10.3389/fonc.2021.771802. eCollection 2021.
Premalignant Changes in the Bronchial Epithelium Are Prognostic Factors of Distant Metastasis in Non-Small Cell Lung Cancer Patients.
Frontiers in oncology
Olga V Pankova, Liubov A Tashireva, Evgeny O Rodionov, Sergey V Miller, Sergey A Tuzikov, Dmitry S Pismenny, Tatiana S Gerashchenko, Marina V Zavyalova, Sergey V Vtorushin, Evgeny V Denisov, Vladimir M Perelmuter
Affiliations
Affiliations
- Cancer Research Institute, Tomsk National Research Medical Center, Tomsk, Russia.
- Department of Pathological Anatomy, Siberian State Medical University State Medical University, Tomsk, Russia.
- Department of Organic Chemistry, Tomsk State University, Tomsk, Russia.
PMID: 34858851
PMCID: PMC8631511 DOI: 10.3389/fonc.2021.771802
Abstract
BACKGROUND: The study assessed the possibility of dividing patients into groups based on the assessment of morphological changes in the epithelium of small-caliber bronchi located near the primary tumor in order to predict high and low risks of distant metastasis of non-small cell lung cancer.
METHODS: In 171 patients with non-small cell lung cancer (T
RESULTS: During the follow-up period, distant metastases were found in 35.1% (60/171) of patients. Most often, they were observed in patients of the high-risk group: BCH+SM-D- (51.6%, 40/95) and BCH-SM+D+ (54.4%, 6/11). Less often, distant metastases were observed in low-risk group patients: BCH+SM+D- (6.7%, 3/45) and BCH-SM-D- (10.0%, 2/20). Tumor size, grade, and stage were significant predictors of metastasis only in the high-risk group. The 5-year metastasis-free survival was better in the low-risk group of distant metastases.
CONCLUSIONS: Isolated BCH or dysplasia in small bronchi distant from foci of tumor is associated with a high-risk distant metastasis and less 5-year metastasis-free survival.
Copyright © 2021 Pankova, Tashireva, Rodionov, Miller, Tuzikov, Pismenny, Gerashchenko, Zavyalova, Vtorushin, Denisov and Perelmuter.
Keywords: basal cell hyperplasia; bronchial lesion; distant metastasis; metastasis-free survival; non-small cell lung cancer (NSCLC); squamous cell metaplasia
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
References
- Clin Cancer Res. 2014 Apr 1;20(7):1946-54 - PubMed
- Transl Lung Cancer Res. 2020 Aug;9(4):988-999 - PubMed
- Ann Oncol. 2017 Jul 1;28(suppl_4):iv1-iv21 - PubMed
- Int J Cancer. 2021 Apr 5;: - PubMed
- Respir Res. 2002;3:20 - PubMed
- Appl Immunohistochem Mol Morphol. 2020 Jul;28(6):477-483 - PubMed
- Tumour Biol. 2016 Mar;37(3):3599-607 - PubMed
- J Thorac Oncol. 2012 Apr;7(4):723-30 - PubMed
- Radiat Oncol. 2013 Dec 09;8:286 - PubMed
Publication Types